Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin e syndrome: Genetic and clinical studies of six patients

Journal of Clinical Immunology

Volumn 34, Issue 2, 2014, Pages 163-170

  Wolach, Ofir ^a,e   Kuijpers, Taco ^b   Ben Ari, Josef ^c,e   Gavrieli, Ronit ^c,e   Feinstein Goren, Neta ^d,e   Alders, Marielle ^e,f   Garty, Ben Zion ^d,e   Wolach, Baruch ^c,e  

^a RABIN MEDICAL CENTER   (Israel)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c MEIR MEDICAL CENTER   (Israel)

^d SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Autosomal dominant Hyperimmunoglobulin E Syndrome; Clinical expressivity; STAT3 mutations

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; FLUCONAZOLE; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN E; ITRACONAZOLE; STAT3 PROTEIN; VORICONAZOLE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOMA; ASPERGILLOSIS; ATELECTASIS; AUTOSOMAL DOMINANT HYPER IGE SYNDROME; BRONCHOPLEURAL FISTULA; CANDIDIASIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CODING; CRYPTOCOCCAL MENINGITIS; DNA BINDING; ECZEMA; EXON; FEMALE; FRACTURE; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HYPER IGE SYNDROME; LUNG ABSCESS; LYMPHADENITIS; LYMPHOMA; MALE; NATIONAL INSTITUTE OF HEALTH SCORE; PHENOTYPE; PLEURA EFFUSION; PNEUMATOCELE; PNEUMOCYSTIS PNEUMONIA; PNEUMOTHORAX; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SCOLIOSIS; SCORING SYSTEM; SEPSIS; SKIN ABSCESS; SUPPURATIVE OTITIS MEDIA; UPPER RESPIRATORY TRACT INFECTION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; DERMATITIS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; IMMUNOGLOBULIN ISOTYPES; JOB SYNDROME; MALE; MUTATION; PEDIGREE; STAT3 TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 84898877252     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-9988-4     Document Type: Article

References (19)

1. Freeman AF, Holland SM. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res. 2009;65:32R-7R.
2. Minegishi Y. Hyper-IgE syndrome. Curr Opin Immunol. 2009;21:487-92.
3. Woellner C, Gertz EM, Schaffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125:424-32. e428.
4. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-ige syndrome. N Engl J Med. 2007;357:1608-19.
5. Heimall J, Freeman A, Holland SM. Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol. 2010;38:32-8.
6. Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: Molecular, cellular, and clinical features from a french national survey. Medicine (Baltimore). 2012;91:e1-e19.
7. Heimall J, Davis J, Shaw PA, Hsu AP, Gu W, Welch P, et al. Paucity of genotype-phenotype correlations in STAT3 mutation positive hyper IgE syndrome (hies). Clin Immunol. 2011;139:75-84.
8. Wolach B, Eliakim A, Pomeranz A, Cohen AH, Nusbacher J, Metzker A. Cyclosporin treatment of hyperimmunoglobulin E syndrome. Lancet. 1996;347:67.
9. Grimbacher B, Schaffer AA, Holland SM, Davis J, Gallin JI, Malech HL, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65:735-44.
10. Garty BZ, Ben-Baruch A, Rolinsky A, Woellner C, Grimbacher B, Marcus N. Pneumocystis Jirovecii pneumonia in a baby with hyper-IgE syndrome. Eur J Pediatr. 2010;169:35-7.
11. Davis SD, Schaller J, Wedgwood RJ. Job's syndrome. Recurrent, "Cold", staphylococcal abscesses. Lancet. 1966;1:1013-5.
12. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058-62.
13. Renner ED, Torgerson TR, Rylaarsdam S, Anover-Sombke S, Golob K, LaFlam T, et al. STAT3 mutation in the original patient with job's syndrome. N Engl J Med. 2007;357:1667-8.
14. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, et al. Enhanced th1 activity and development of chronic enterocolitis in mice devoid of STAT3 in macrophages and neutrophils. Immunity. 1999;10:39-49.
15. Avery DT, Ma CS, Bryant VL, Santner-Nanan B, Nanan R, Wong M, et al. STAT3 is required for il-21-induced secretion of IgE from human naive B cells. Blood. 2008;112:1784-93.
16. Wolach B, Gavrieli R, Roos D, Berger-Achituv S. Lessons learned from phagocytic function studies in a large cohort of patients with recurrent infections. J Clin Immunol. 2012;32:454-66.
17. Hsu AP, Sowerwine KJ, Lawrence MG, Davis J, Henderson CJ, Zarember KA, Garofalo M, Gallin JI, Kuhns DB, Heller T, Milner JD, Puck JM, Freeman AF, Holland SM: Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism. J Allergy Clin Immunol 2013.
18. Tsuda K, Yamanaka K, Kitagawa H, Akeda T, Naka M, Niwa K, et al. Calcineurin inhibitors suppress cytokine production from memory t cells and differentiation of naive t cells into cytokine-producing mature T cells. PLoS One. 2012;7:e31465.
19. Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced t(h)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008;122:181-7.